How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation

British Journal of Haematology

Volumn 168, Issue 4, 2015, Pages 481-491

  Carreras, Enric ^a,b,c  

^a HOSPITAL CLÍNIC   (Spain)

^b Josep Carreras Leukaemia Research Institute   (Spain)

^c JOSEP CARRERAS LEUKAEMIA RESEARCH INSTITUTE IJC   (Spain)

Author keywords

Defibrotide; Early complications post HCT; Endothelial damage; Sinusoidal obstruction syndrome; Veno occlusive disease of the liver

Indexed keywords

ACETYLCYSTEINE; ALTEPLASE; ANTITHROMBIN III; BUSULFAN; CYCLOPHOSPHAMIDE; DEFIBROTIDE; DIURETIC AGENT; FLUDARABINE; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE; PROSTAGLANDIN E1; PROTEIN C; URSODEOXYCHOLIC ACID; POLYDEOXYRIBONUCLEOTIDE;

ALLOTRANSPLANTATION; ASCITES; CELL TRANSPLANTATION; CHEMOPROPHYLAXIS; CLINICAL CRITERIA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; EARLY INTERVENTION; EDEMA; ENDOTHELIUM CELL; FLUID BALANCE; GRAFT VERSUS HOST REACTION; HEALTH CARE POLICY; HEMATOPOIETIC CELL TRANSPLANTATION; HEPATOMEGALY; HEPATORENAL SYNDROME; HIGH RISK PATIENT; HISTOCOMPATIBILITY; HUMAN; INCIDENCE; JAUNDICE; LIVER TRANSPLANTATION; LIVER VENOOCCLUSIVE DISEASE; MEDICAL HISTORY; MULTIPLE ORGAN FAILURE; MYELOABLATIVE CONDITIONING; PATHOGENESIS; PATIENT MONITORING; REDUCED INTENSITY CONDITIONING; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SURVIVAL RATE; THROMBOCYTOPENIA; TIME TO TREATMENT; TREATMENT DURATION; WEIGHT CONTROL; WEIGHT GAIN; WHOLE BODY RADIATION; ADVERSE EFFECTS; DISEASE MANAGEMENT; DRUG COMBINATION; DRUG EFFECTS; EARLY DIAGNOSIS; FLUID THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; IMMUNOSUPPRESSIVE TREATMENT; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; SYMPTOM ASSESSMENT; VASCULAR ENDOTHELIUM;

COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; EARLY DIAGNOSIS; ENDOTHELIUM, VASCULAR; FLUID THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; METHYLPREDNISOLONE; MULTIPLE ORGAN FAILURE; POLYDEOXYRIBONUCLEOTIDES; RISK FACTORS; SYMPTOM ASSESSMENT; TRANSPLANTATION CONDITIONING;

EID: 84923093541     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13215     Document Type: Review

References (87)

1. Al Beihany, A., Al Omar, H., Sahovic, E., Chaudhri, N., Al Mohareb, F., Al Sharif, F., Al Zahrani, H., Al Shanqeeti, A., Seth, P., Zaidi, S., Morshed, M., Al Anazi, K., Mohamed, G., Gyger, M. & Aljurf, M. (2008) Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone. Bone Marrow Transplantation, 41, 287-291.
2. Attal, M., Huguet, F., Rubie, H., Huynh, A., Charlet, J.P., Payen, J.L., Voigt, J.J., Brousset, P., Selves, J. & Muller, C. (1992) Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous in-fusion of low-dose heparin: a prospective, randomized trial. Blood, 79, 2834-2840.
3. Attal, M., Huguet, F., Rubie, H., Charlet, J.P., Schlaifer, D., Huynh, A., Laurent, G. & Pris, J. (1993) Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial. Blood, 82, 732-736.
4. Azoulay, D., Castaing, D., Lemoine, A., Hargreaves, G.M. & Bismuth, H. (2000) Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation. Bone Marrow Transplantation, 25, 987-992.
5. Bacq, Y., Gaudin, C., Hadengue, A., Roulot, D., Braillon, A., Moreau, R. & Lebrec, D. (1991) Systemic, splanchnic and renal hemodinamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. Hepatology, 14, 483-487.
6. Barkholt, L., Remberger, M., Hassan, Z., Fransson, K., Omazic, B., Svahn, B.M., Karlsson, H., Brune, M., Hassan, M., Mattsson, J. & Ringdén, O. (2008) A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 41, 785-790.
7. Bearman, S.I., Hinds, M.S., Wolford, J.L., Petersen, F.B., Nugent, D.L., Slichter, S.J., Shulman, H.M. & McDonald, G.B. (1990) A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Bone Marrow Transplantation, 5, 407-411.
8. Bearman, S.I., Anderson, G.L., Mori, M., Hinds, M.S., Shulman, H.M. & McDonald, G.B. (1993a) Veno-occlusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. Journal of Clinical Oncology, 11, 1729-1736.
9. Bearman, S.I., Shen, D.D., Hinds, M.S., Hill, H.A. & McDonald, G.B. (1993b) A phase I/II study of prostaglandin E1 for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. British Journal of Haematology, 84, 724-730.
10. Bearman, S.I., Lee, J.L., Barón, A.E. & McDonald, G.B. (1997) Treatment of hepatic veno-occlusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood, 89, 1501-1506.
11. Bulley, S.R., Strahm, B., Doyle, J. & Dupuis, L.L. (2007) Defibrotide for the treatment of hepatic veno-occlusive disease in children. Pediatric Blood Cancer, 48, 700-704.
12. Cantoni, N., Gerull, S., Heim, D., Halter, J., Bucher, C., Buser, A., Tsakiris, D.A., Passweg, J., Tichelli, A., Stern, M. & Gratwohl, A. (2011) Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT. Bone Marrow Transplantation, 46, 344-349.
13. Cappelli, B., Chiesa, R., Evangelio, C., Biffi, A., Roccia, T., Frugnoli, I., Biral, E., Noè, A., Fossati, M., Finizio, V., Miniero, R., Napolitano, S., Ferrua, F., Soliman, C., Ciceri, F., Roncarolo, M.G. & Marktel, S. (2009) Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan. British Journal of Haematology, 147, 554-560.
14. Carmona, A., Díaz-Ricart, M., Palomo, M., Molina, P., Pino, M., Rovira, M., Escolar, G. & Carreras, E. (2013) Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide. Biology of Blood and Marrow Transplantation, 19, 1439-1445.
15. Carreras, E. (2000) Veno-occlusive disease of the liver after hematopoietic cell transplantation. European Journal of Haematology, 64, 281-291.
16. Carreras, E. (2012) Early complications after HSCT. In: EBMT Handbook of Hematopoietic Stem Cell Transplantation (ed. by J. Apperley, E. Carreras, E. Gluckman & T. Mazzi ), pp. 177-194. Forum Service Editore, Genoa, Italy.
17. Carreras, E. & Diaz-Ricart, M. (2011) The role of the endothelium in the short-term complications of hematopoietic SCT. Bone Marrow Transplantation, 46, 1495-1502.
18. Carreras, E., Grañena, A., Navasa, M., Bruguera, M., Marco, V., Sierra, J., Tassies, M.D., García-Pagán, J.C., Martí, J.M., Bosch, J., Rodés, J. & Rozman, C. (1993a) On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease. Annals of Hematology, 66, 77-80.
19. Carreras, E., Grañena, A., Navasa, M., Bruguera, M., Marco, V., Sierra, J., Tassies, M.D., García-Pagán, J.C., Martí, J.M., Bosch, J., Rodés, J. & Rozman, C. (1993b) Transjugular liver biopsy in BMT. Bone Marrow Transplantation, 11, 21-26.
20. Carreras, E., Bertz, H., Arcese, W., Vernant, J.P., Tomás, J.F., Hagglund, H., Bandini, G., Esperou, H., Russell, J., de la Rubia, J., Di Girolamo, G., Demuynck, H., Hartmann, O., Clausen, J., Ruutu, T., Leblond, V., Iriondo, A., Bosi, A., Ben-Bassat, I., Koza, V., Gratwohl, A. & Apperley, J.F. (1998) Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. Blood, 92, 3599-3604.
21. Carreras, E., Rosiñol, L., Terol, M.J., Alegre, A., de Arriba, F., García-Laraña, J., Bello, J.L., García, R., León, A., Martínez, R., Peñarrubia, M.J., Poderós, C., Ribas, P., Ribera, J.M., San Miguel, J., Bladé, J. & Lahuerta, J.J. (2007) Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients. Biology of Blood and Marrow Transplantation, 13, 1448-1454.
22. Carreras, E., Díaz-Beyá, M., Rosiñol, L., Martínez, C., Fernández-Avilés, F. & Rovira, M. (2011) The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biology of Blood and Marrow Transplantation, 17, 1713-1720.
23. Chalandon, Y., Roosnek, E., Mermillod, B., Newton, A., Ozsahin, H., Wacker, P., Helg, C. & Chapuis, B. (2004) Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 10, 347-354.
24. Chao, N. (2014) How I treat sinusoidal obstruction syndrome. Blood, 123, 4023-4026.
25. Chopra, R., Eaton, J.D., Grassi, A., Potter, M., Shaw, B., Salat, C., Neumeister, P., Finazzi, G., Iacobelli, M., Bowyer, K., Prentice, H.G. & Barbui, T. (2000) Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. British Journal of Haematology, 111, 1122-1129.
26. Clift, R.A., Bianco, J.A., Appelbaum, F.R., Buckner, C.D., Singer, J.W., Bakke, L., Bensinger, W.I., Bowden, R.A., McDonald, G.B. & Schubert, M. (1993) A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation. Blood, 82, 2025-2030.
27. Coppell, J.A., Richardson, P.G., Soiffer, R., Martin, P.L., Kernan, N.A., Chen, A., Guinan, E., Vogelsang, G., Krishnan, A., Giralt, S., Revta, C., Carreau, N.A., Iacobelli, M., Carreras, E., Ruutu, T., Barbui, T., Antin, J.H. & Niederwieser, D. (2010) Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biology of Blood and Marrow Transplantation, 16, 157-168.
28. Corbacioglu, S., Greil, J., Peters, C., Wulffraat, N., Laws, H.J., Dilloo, D., Straham, B., Gross-Wieltsch, U., Sykora, K.W., Ridolfi-Lüthy, A., Basu, O., Gruhn, B., Güngör, T., Mihatsch, W. & Schulz, A.S. (2004) Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplantation, 33, 189-195.
29. Corbacioglu, S., Hönig, M., Lahr, G., Stöhr, S., Berry, G., Friedrich, W. & Schulz, A.S. (2006) Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide. Bone Marrow Transplantation, 38, 547-553.
30. Corbacioglu, S., Carreras, E., Niederwieser, D.W., Sardella, M., Hoyle, M., Hume, R., Massaro, J., Hannah, A.L., Iacobelli, M., Richardson, P.G. & Defibrotide Study Group (2010) Safety of Defibrotide (DF) In Stem Cell Transplant (SCT) Patients. Blood, 116, 3482.
31. Corbacioglu, S., Cesaro, S., Faraci, M., Valteau-Couanet, D., Gruhn, B., Rovelli, A., Boelens, J.J., Hewitt, A., Schrum, J., Schulz, A.S., Müller, I., Stein, J., Wynn, R., Greil, J., Sykora, K.W., Matthes-Martin, S., Führer, M., O'Meara, A., Toporski, J., Sedlacek, P., Schlegel, P.G., Ehlert, K., Fasth, A., Winiarski, J., Arvidson, J., Mauz-Körholz, C., Ozsahin, H., Schrauder, A., Bader, P., Massaro, J., D'Agostino, R., Hoyle, M., Iacobelli, M., Debatin, K.M., Peters, C. & Dini, G. (2012a) Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet, 379, 1301-1309.
32. Corbacioglu, S., Kernan, N., Lehmann, L., Brochstein, J., Revta, C., Grupp, S., Martin, P. & Richardson, P.G. (2012b) Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Expert Review of Hematology, 5, 291-302.
33. Cutler, C., Stevenson, K., Kim, H.T., Richardson, P., Ho, V.T., Linden, E., Revta, C., Ebert, R., Warren, D., Choi, S., Koreth, J., Armand, P., Alyea, E., Carter, S., Horowitz, M., Antin, J.H. & Soiffer, R. (2008) Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. Blood, 112, 4425-4431.
34. Cutler, C., Kim, H.T., Ayanian, S., Bradwin, G., Revta, C., Aldridge, J., Ho, V., Alyea, E., Koreth, J., Armand, P., Soiffer, R., Ritz, J., Richardson, P.G. & Antin, J.H. (2010) Prediction of veno-occlusive disease using biomarkers of endothelial injury. Biology of Blood and Marrow Transplantation, 16, 1180-1185.
35. Daly, A., Savoie, M.L., Geddes, M., Chaudhry, A., Stewart, D., Duggan, P., Bahlis, N., Storek, J., Brown, C., Shafey, M., Turner, A.R. & Russell, J. (2012) Fludarabine, busulfan, antithymocyte globulin, and total body irradiation for pre-transplantation conditioning in acute lymphoblastic leukemia: excellent outcomes in all but older patients with comorbidities. Biology of Blood and Marrow Transplantation., 18, 1921-1926.
36. Deeg, H.J., Shulman, H.M., Schmidt, E., Yee, G.C., Thomas, E.D. & Storb, R. (1986) Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine. Transplantation, 42, 497-501.
37. DeLeve, L.D., Wang, X., Kuhlenkamp, J.F. & Kaplowitz, N. (1996) Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic veno-occlusive disease. Hepatology, 23, 589-599.
38. Dignan, F., Gujral, D., Ethell, M., Evans, S., Treleaven, J., Morgan, G. & Potter, M. (2007) Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease. Bone Marrow Transplantation, 40, 79-82.
39. Dignan, F.L., Wynn, R.F., Hadzic, N., Karani, J., Quaglia, A., Pagliuca, A., Veys, P., Potter, M.N., Haemato-Oncology Task Force of British Committee for Standards in Haematology & British Society for Blood and Marrow Transplantation (2013) BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. British Journal of Haematology, 163, 444-457.
40. Eber, S.W., Gungor, T., Veldman, A., Sykora, K., Scherer, F., Fischer, D. & Grigull, L. (2007) Favorable response of pediatric stem cell recipients to human protein C concentrate substitution for veno-occlusive disease. Pediatric Transplantation, 11, 49-57.
41. Essell, J.H., Schroeder, M., Harman, G.S., Holvorson, R., Lew, V., Callander, N., Snyder, M., Lewis, S.K., Allerton, J.P. & Thompson, J.M. (1998) Ursodiol prophylaxis against hepatic complications of allogeneic stem cell trans-plantation. A randomized double-blind, placebo-controlled trial. Annals of Internal Medicine, 128, 975-981.
42. Ferrà, C., de Sanjosé, S., Lastra, C.F., Martí, F., Mariño, E.L., Sureda, A., Brunet, S., Gallardo, D., Berlanga, J.J., García, J. & Grañena, A. (1997) Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications. Bone Marrow Transplantation, 20, 1075-1080.
43. Forrest, D.L., Thompson, K., Dorcas, V.G., Couban, S.H. & Pierce, R. (2003) Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study. Bone Marrow Transplantation, 31, 1143-1149.
44. Gluckman, E., Jolivet, I., Scrobohaci, M.L., Devergie, A., Traineau, R., Bourdeau-Esperou, H., Lehn, P., Faure, P. & Drouet, L. (1990) Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. British Journal of Haematology, 74, 277-281.
45. Gooley, T.A., Chien, J.W., Pergam, S.A., Hingorani, S., Sorror, M.L., Boeckh, M., Martin, P.J., Sandmaier, B.M., Marr, K.A., Appelbaum, F.R., Storb, R. & McDonald, G.B. (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. New England Journal of Medicine, 363, 2091-2101.
46. Ha, E. & Mun, K.C. (2012) Effects of cyclosporine on metalloproteinase in endothelial cells. Transplantation Proceedings, 44, 991-992.
47. Hägglund, H., Remberger, M., Klaesson, S., Lönnqvist, B., Ljungman, P. & Ringden, O. (1998) Norethisterone treatment, a major risk factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation. Blood, 92, 4568-4572.
48. Haussmann, U., Fischer, J., Eber, S., Scherer, F., Seger, R. & Gungor, T. (2006) Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy. Haematologica, 91, 795-800.
49. Ibrahim, A., Pico, J.L., Maraninchi, D., Zambon, E., Attal, M., Brault, P., Tilly, H., Blaise, D. & Hayat, M. (1991) Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1. Bone Marrow Transplantation, 7(Suppl 2), 53.
50. Imran, H., Tleyjeh, I.M., Zirakzadeh, A., Rodriguez, V. & Khan, S.P. (2006) Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis. Bone Marrow Transplantation, 37, 677-686.
51. Jones, R.J., Lee, K.S., Beschorner, W.E., Vogel, V.G., Grochow, L.B., Braine, H.G., Vogelsang, G.B., Sensenbrenner, L.L., Santos, G.W. & Saral, R. (1987) Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation, 44, 778-783.
52. Koenecke, C., Kleine, M., Schrem, H., Krug, U., Nashan, B., Neipp, M., Ganser, A., Hertenstein, B. & Klempnauer, J. (2006) Sinusoidal obstruction syndrome of the liver after hematopoietic stem cell transplantation: decision making for orthotopic liver transplantation. International Journal of Hematology, 83, 271-274.
53. Kumar, S., DeLeve, L.D., Kamath, P.S. & Tefferi, A. (2003) Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clinic Proceedings, 78, 589-598.
54. Lee, J.L., Gooley, T., Bensinger, W., Schiffman, K. & McDonald, G.B. (1999) Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome. Biology of Blood and Marrow Transplantation, 5, 306-315.
55. Marsa-Vila, L., Gorin, N.C., Laporte, J.P., Labopin, M., Dupuy-Montbrun, M.C., Fouillard, L., Isnard, F. & Najman, A. (1991) Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation. European Journal of Haematology, 47, 346-354.
56. McDonald, G.B., Sharma, P., Matthews, D.E., Shulman, H.M. & Thomas, E.D. (1984) Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology, 4, 116-122.
57. McDonald, G.B., Hinds, M.S., Fisher, L.D., Schoch, H.G., Wolford, J.L., Banaji, M., Hardin, B.J., Shulman, H.M. & Clift, R.A. (1993) Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Annals of Internal Medicine, 118, 255-267.
58. Moscardó, F., Urbano-Ispizua, A., Sanz, G.F., Brunet, S., Caballero, D., Vallejo, C., Solano, C., Pimentel, P., Pérez de Oteyza, J., Ferrá, C., Díez-Martín, J.L., Zuazu, J., Espigado, I., Campilho, F., Arbona, C., Moraleda, J.M., Mateos, M.V., Sierra, J., Talarn, C. & Sanz, M.A. (2003) Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. Experimental Hematology, 31, 545-550.
59. Myers, K.C., Lawrence, J., Marsh, R.A., Davies, S.M. & Jodele, S. (2013) High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients. Biology of Blood and Marrow Transplantation, 19, 500-503.
60. Ohashi, K., Tanabe, J., Watanabe, R., Tanaka, T., Sakamaki, H., Maruta, A., Okamoto, S., Aotsuka, N., Saito, K., Nishimura, M., Oh, H., Matsuzaki, M., Takahashi, S. & Yonekura, S. (2000) The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation. American Journal of Hematology, 64, 32-38.
61. Or, O., Nagler, A., Shpilberg, O., Elad, S., Naparstek, E., Kapelushnik, J., Cass, Y., Gillis, S., Chetrit, A., Slavin, S. & Eldor, A. (1996) Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients. Transplantation, 61, 1067-1071.
62. Palomo, M., Diaz-Ricart, M., Carbo, C., Rovira, M., Fernandez-Aviles, F., Martinez, C., Ghita, G., Escolar, G. & Carreras, E. (2010) Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation. Biology of Blood and Marrow Transplantation, 16, 985-993.
63. Palomo, M., Diaz-Ricart, M., Rovira, M., Escolar, G. & Carreras, E. (2011) Defibrotide prevents the activation of macrovascular and microvascular endothelia caused by soluble factors released to blood by autologous hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 17, 497-506.
64. Park, S.H., Lee, M.H., Lee, H., Kim, H.S., Kim, K., Kim, W.S., Jung, C.W., Im, Y.H., Yoon, S.S., Kang, W.K., Park, K., Park, C.H. & Kim, S.W. (2002) A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation. Bone Marrow Transplantation, 29, 137-143.
65. Penack, O., Socié, G. & van den Brink, M.R. (2011) The importance of neovascularization and its inhibition for allogeneic hematopoietic stem cell transplantation. Blood, 117, 4181-4189.
66. Peres, E., Kintzel, P., Dansey, R., Baynes, R., Abidi, M., Klein, J., Ibrahim, R.B. & Abella, E. (2008) Early intervention with antithrombin III therapy to prevent progression of hepatic veno-occlusive disease. Blood Coagulation & Fibrinolysis, 19, 203-207.
67. Richardson, P.G., Elias, A.D., Krishnan, A., Wheeler, C., Nath, R., Hoppensteadt, D., Kinchla, N.M., Neuberg, D., Waller, E.K., Antin, J.H., Soiffer, R., Vredenburgh, J., Lill, M., Woolfrey, A.E., Bearman, S.I., Iacobelli, M., Fareed, J. & Guinan, E.C. (1998) Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood, 92, 737-744.
68. Richardson, P.G., Murakami, C., Jin, Z., Warren, D., Momtaz, P., Hoppensteadt, D., Elias, A.D., Antin, J.H., Soiffer, R., Spitzer, T., Avigan, D., Bearman, S.I., Martin, P.L., Kurtzberg, J., Vredenburgh, J., Chen, A.R., Arai, S., Vogelsang, G., McDonald, G.B. & Guinan, E.C. (2002) Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood, 100, 4337-4343.
69. Richardson, P., Tomblyn, M., Kernan, N., Brochstein, J.A., Mineishi, S., Termuhlen, A., Arai, S., Grupp, S.A., Guinan, E., Martin, P.L., Corbacioglu, S., Holler, E., Agostino, R., Massaro, J., Hannah, A.L., Iacobelli, M. & Soiffer, R.J. (2009) Defibrotide (DF) in the treatment of severe hepatic veno-occlusive disease (VOD) with multi-organ failure (MOF) following stem cell transplantation (SCT): results of a phase 3 study utilizing a historical control. Blood, 114, 654.
70. Richardson, P.G., Soiffer, R.J., Antin, J.H., Uno, H., Jin, Z., Kurtzberg, J., Martin, P.L., Steinbach, G., Murray, K.F., Vogelsang, G.B., Chen, A.R., Krishnan, A., Kernan, N.A., Avigan, D.E., Spitzer, T.R., Shulman, H.M., Di Salvo, D.N., Revta, C., Warren, D., Momtaz, P., Bradwin, G., Wei, L.J., Iacobelli, M., McDonald, G.B. & Guinan, E.C. (2010a) Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biology of Blood and Marrow Transplantation, 16, 1005-1017.
71. Richardson, P.G., Steinbach, G., Kernan, N., Guinan, E.C., Chen, A.R., Martin, P.L., Krishnan, A., Arai, S., Brochstein, J.A., Grupp, S.A., Mineishi, S., Termuhlen, A., Tomblyn, M., Antin, J.H., Revta, C., Hume, R., Massaro, J., Hannah, A.L., Iacobelli, M., Soiffer, R.J. & Defibrotide Study Group (2010b) Meta-analysis of defibrotide (DF) in the treatment of severe hepatic veno-occlusive disease (VOD) with multi-organ failure (MOF) with comparison to a historical control (HC). Blood, 116, 3481.
72. Richardson, P.G., Ho, V.T., Giralt, S., Arai, S., Mineishi, S., Cutler, C., Antin, J.H., Stavitzski, N., Niederwieser, D., Holler, E., Carreras, E. & Soiffer, R. (2012) Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease. Therapeutic Advances in Hematology, 3, 253-265.
73. Richardson, P.G., Ho, V.T., Cutler, C., Glotzbecker, B., Antin, J.H. & Soiffer, R. (2013a) Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions. Biology of Blood and Marrow Transplantation, 19, S88-S90.
74. Richardson, P.G., Smith, A.R., Triplett, B.M., Kernan, N.A., Grupp, S.A., Arai, S., Haut, P.R., Martin, P.L., Symons, H.J., Lehmann, L.E., Simms-Waldrip, T., Gillio, III, A.P., Horn, B.N., Shore, T.B., Krishnan, A.Y., Petrovic, A., Kirov, I.I., Woolfrey, A.E., Greiner, R.J., Mineishi, Shin., Boyer, M., Hannah, A.L., Antin, J.H., Hume, R., Bandiera, V., Heringa, C., Soiffer, R.J. & Defibrotide Study Group (2013b) Results of the large prospective study on the use of Defibrotide (DF) in the treatment of hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early intervention improves outcome - Updated results of a treatment IND (T-IND) Expanded Access Protocol. Blood, 122, 700.
75. Rio, B., Andreu, G., Nicod, A., Arrago, J.P., Dutrillaux, F., Samama, M. & Zittoun, R. (1986) Thrombocytopenia in veno-occlusive disease after bone marrow transplantation or chemotherapy. Blood, 67, 1773-1776.
76. Rosenthal, J., Sender, L., Seccola, R., Killen, R., Millerick, M., Murphy, L. & Cairo, M.S. (1996) Phase II trial of heparin prophylaxis for veno-occlusive of the liver in children undergoing bone marrow transplantation. Bone Marrow Transplantation, 18, 185-191.
77. Ruutu, T., Juvonen, E., Remberger, M., Remes, K., Volin, L., Mattsson, J., Nihtinen, A., Hägglund, H., Ringdén, O. & Nordic Group for Blood and Marrow Transplantation (2014) Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study. Biology of Blood and Marrow Transplantation, 20, 135-138.
78. Salat, C., Holler, E., Kolb, H.J., Pihusch, R., Reinhardt, B., Penovici, M., Ledderose, G. & Hiller, E. (1999) The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation. Leukemia and Lymphoma, 33, 25-32.
79. Shulman, H.M., Fisher, L.B., Schoch, H.G., Kenne, K.W. & McDonald, G.B. (1984) Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology, 19, 1171-1180.
80. Shulman, H.M., Gooley, T., Dudley, M.D., Kofler, T., Feldman, R., Dwyer, D. & McDonald, G.B. (1995) Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow recipients. Transplantation, 59, 1015-1022.
81. Simon, M., Hahn, T., Ford, L.A., Anderson, B., Swinnich, D., Baer, M.R., Bambach, B., Bernstein, S.H., Bernstein, Z.P., Czuczman, M.S., Slack, J.L., Wetzler, M., Herzig, G., Schriber, J. & McCarthy, P.L. Jr (2001) Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin. Bone Marrow Transplantation, 27, 627-633.
82. Soiffer, R.J., Dear, K., Rabinowe, S.N., Anderson, K.C., Freedman, A.S., Murray, C., Tarbell, N.J., Mauch, P., Nadler, L.M. & Ritz, J. (1991) Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation. Transplantation, 52, 1014-1019.
83. Song, J.S., Seo, J.J., Moon, H.N., Ghim, T. & Im, H.J. (2006) Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children. Journal of Korean Medical Science, 21, 897-903.
84. Strasser, S.I. & McDonald, G.B. (2009) Gastrointestinal and hepatic complications. In: Thomas' Hematopoietic Cell Transplantation, 4th edn (ed. by F.R. Appelbaum, S.J. Forman, S.J. Negrin & K.G. Blume ), pp. 1434-1455. Blackwell Publishing, Malden, MA.
85. Tay, J., Tinmouth, A., Fergusson, D., Huebsch, L. & Allan, D.S. (2007) Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation., 13, 206-217.
86. Tefferi, A. (2011) Iron overload and stem cell transplant-and the beat goes on. American Journal of Hematology, 86, 825?826.
87. Zager, R.A., O'Quigley, J., Zager, B.K., Alpers, C.E., Shulman, H.M., Gamelin, L.M., Stewart, P. & Thomas, E.D. (1989) Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. American Journal of Kidney Diseases, 13, 210-216.